Drug recall · December 5, 2012
Pradaxa recall
Why: Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54
- Lots / codes
Lot 201900 Expiration Date: JAN 2015
- Quantity
- 8,381 bottles
- Company
- Boehringer Ingelheim Roxane Inc, Columbus, OH
- Distribution
- Nationwide
- Initiated
- November 5, 2012 · Voluntary: Firm initiated
- Classified
- November 26, 2012
- Reported
- December 5, 2012
- Ended
- September 18, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dabigatran etexilate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.